Preparation and characterization of monoclonal antibodies against GAM protein: a novel gp130-associated molecule

F Liu1, Y Liu, B Jin

  • 1Department of Immunology, The 4th Military Medical University, Xi'an, P.R. China.

Hybridoma
|November 26, 1999
PubMed

Insights

Monoclonal antibodies (MAbs) were developed to study gp130-associated-molecule (GAM), a protein involved in gp130 and Notch signaling pathways. These MAbs enable detection and characterization of GAM, including its nuclear polymerization.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Signaling

Background:

  • gp130-associated-molecule (GAM) is a novel protein with homology to Groucho/TLE co-repressors.
  • GAM interacts with gp130 and influences JAKs association and tyrosine phosphorylation.
  • Understanding GAM's role in signaling pathways like Notch is crucial.

Purpose of the Study:

  • To develop high-affinity monoclonal antibodies (MAbs) against GAM.
  • To utilize these MAbs for detecting and characterizing GAM in cellular contexts.
  • To investigate GAM's function in gp130 and Notch signaling.

Main Methods:

  • Expression and purification of GAM-Thioredoxin (Thio) fusion protein.
  • Generation of anti-GAM MAbs using hybridoma technology.
  • Detection of GAM using Western blotting and flow cytometry; analysis of GAM polymerization.

Main Results:

  • Three high-affinity MAbs recognizing distinct GAM epitopes were successfully generated.
  • MAbs confirmed GAM expression and detected increased GAM in transfected cells.
  • Western blotting revealed GAM forms 110 kDa polymers in the nucleus.

Conclusions:

  • The developed MAbs are effective tools for studying GAM.
  • These MAbs facilitate investigation into GAM's role in gp130 and Notch signaling.
  • GAM polymerization in the nucleus suggests a novel regulatory mechanism.